Eli Lilly and CompanyLLYNYSE
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+35.6%
5Y CAGR+23.4%
Year-over-Year Change
Revenue minus cost of goods sold
3Y CAGR
+35.6%/yr
vs +6.8%/yr prior
5Y CAGR
+23.4%/yr
Recent acceleration
Acceleration
+28.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.9x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $54.62B | +49.1% |
| 2024 | $36.62B | +35.4% |
| 2023 | $27.04B | +23.4% |
| 2022 | $21.91B | +4.3% |
| 2021 | $21.01B | +10.2% |
| 2020 | $19.06B | +8.3% |
| 2019 | $17.60B | +4.7% |
| 2018 | $16.81B | +8.3% |
| 2017 | $15.53B | +0.1% |
| 2016 | $15.51B | - |